Canaccord Genuity Initiates Kite Pharma With Buy
October 28, 2014 at 08:46 AM EDT
Analysts at Canaccord Genuity initiated coverage on shares of Kite Pharma (NASDAQ: KITE) with a Buy rating. The target price for Kite ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.